Natalia Egri

19 papers · 325 indexed citations

Immediate Impact

36 hit

Sub-graph 1 of 18

Unveiling the potential of CLL-1: a promising target for AML therapy

2025 Hit

MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy

2025 Hit

2 intermediate papers

CART manufacturing process and reasons for academy-pharma collaboration

2019

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Natalia Egri	211	85	54	37	34	19	325
Asaf Shemer	82 0.4×	93 1.1×	56 1.0×	40 1.1×	13 0.4×	34	338
Zhihua Wang	207 1.0×	70 0.8×	23 0.4×	10 0.3×	29 0.9×	14	259
Emily Figueiredo Neves Yuki	108 0.5×	48 0.6×	60 1.1×	79 2.1×	13 0.4×	30	221
Eleonora Tartaglia	128 0.6×	45 0.5×	51 0.9×	7 0.2×	16 0.5×	18	249
Marianne Graninger	236 1.1×	51 0.6×	45 0.8×	22 0.6×	23 0.7×	16	276
Laura Thümmler	253 1.2×	76 0.9×	52 1.0×	4 0.1×	21 0.6×	16	292
Laila Hussaini	232 1.1×	54 0.6×	41 0.8×	7 0.2×	8 0.2×	19	346
Veronika Lenz	169 0.8×	68 0.8×	58 1.1×	5 0.1×	9 0.3×	16	302
Laura Pérez‐Alós	247 1.2×	54 0.6×	80 1.5×	6 0.2×	12 0.4×	31	334
Caoilfhionn M Connolly	121 0.6×	61 0.7×	53 1.0×	47 1.3×	28 0.8×	21	233

Loading papers...